Cardiovascular Event Prevalence in Type 1 Versus Type 2 Diabetes: Veradigm Metabolic Registry Insights
DM1 was associated with a lower probability of incident cardiovascular events than DM2. Although DM1 may carry a lower risk of incident cardiovascular events than DM2, the pathophysiology, prevention, and treatment of cardiovascular disease in DM1 remain poorly understood.
Authors
- John A. Spertus (ORCID: https://orcid.org/0000-0002-2839-2611)
- Steven M. Bradley (ORCID: https://orcid.org/0000-0003-4006-6760)
- Amir Lotfi (ORCID: https://orcid.org/0000-0001-8154-8497)
- Andrew M. Goldsweig (ORCID: https://orcid.org/0000-0003-2952-7837)
- Nihar R. Desai (ORCID: https://orcid.org/0000-0003-2384-2545)
- Bracha Goldsweig (ORCID: https://orcid.org/0000-0002-1911-3502)
- Hyo Jung Tak (ORCID: https://orcid.org/0000-0003-1925-3190)
- Alexander Knee (ORCID: https://orcid.org/0000-0001-5656-6095)
Institutions
- Nebraska Medical Center (US)
- Yale New Haven Hospital (US)
- Allina Health (US)
- Baystate Medical Center (US)
- Saint Luke's Health System (US)
- Yale University (US)
- Baystate Health (US)
- Minneapolis Heart Institute Foundation (US)
- University of Nebraska Medical Center (US)
Publication Details
- Journal
- Journal of the Society for Cardiovascular Angiography & Interventions
- Published
- 2025-02-12
- DOI
- https://doi.org/10.1016/j.jscai.2024.102502
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00